Paroxysmal atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria (1) Age between 18 and 85 years regardless of gender. (2) Meets the diagnostic criteria for paroxysmal atrial fibrillation with a frequency of =2 episodes per month or persistent atrial fibrillation (at least one diagnosis confirmed by ECG). (3) Has a correct understanding of the significance of the study demonstrates good compliance with the investigators observations and evaluations and voluntarily agrees to participate in the clinical trial by signing the informed consent form. the investigators observations and evaluations and voluntarily agrees to participate in the clinical trial by signing the informed consent form.
Exclusion criteria
Exclusion criteria: Exclusion Criteria (1) Patients with severe pulmonary hepatic or renal insufficiency primary hematologic diseases or severe cardiac dysfunction (NYHA class IV). (2) Patients with psychiatric disorders that are poorly controlled. (3) Patients with a heart rate below 50 beats per minute (e.g. those planning to receive a pacemaker). (4) Pregnant or lactating women. (5) Patients in the cachectic state of terminal malignant tumors. (6) Patients with known allergies to the study drug components. (7) Patients with poor compliance or those deemed unsuitable for the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dynamic electrocardiogram index;EHRA atrial fibrillation symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale assessment;The cumulative number and duration of palpitations;Summary of the SF-36 Health Survey;proBNP;Cardiac ultrasound;Hamilton Anxiety Scale assessment; | — |
Countries
China
Contacts
Longhua Hospital Shanghai University of Traditional Chinese Medicine